The High Court has directed the government to stop the production and marketing of low-quality medicines by 34 pharmaceutical companies.
On Monday, the bench of justices Salma Masud Chowdhury and Kazi Md Ejarul Haque Akondo slapped an embargo on production and sale of all sorts of medicine by 20 pharmas and antibiotics by 14 other companies.
The bench also ordered the government to take back the low-grade medicine produced by these 34 companies from the market as soon as possible.
The Human Rights and Peace for Bangladesh in a supplementary petition on July 31 notified the court that its order to stop these pharmaceuticals from producing and selling their substandard products was yet to be carried out.
On June 7, the High Court asked the authorities concerned to stop these 34 companies
from producing medicine and antibiotics. The Appellate Division on June 15 upheld the order
The 20 companies to stop production are Avert Pharma, Bikalpa Pharmaceutical, Dolphin Pharmaceuticals, Drugland, Exim Pharmaceutical, Globe Laboratories, Jalpa Laboratories and Kafina Pharmaceuticals, Medico Pharmaceutical, National Drug, North Bengal Pharmaceutical, Rimo Chemical, Rid Pharmaceutical, Skylab Pharmaceutical, Spark Pharmaceutical, Star Pharmaceutical, Sunipun Pharmaceutical, Today Pharmaceutical, Tropical Pharmaceutical and Universal Pharmaceutical.
The 14 companies ordered to stop manufacturing antibiotics are Ad-din Pharmaceuticals, Alkad Pharmaceuticals, Belsen Pharmaceuticals, Bengal Drugs and Chemicals, Bristol Pharma, Crystal Pharmaceuticals, Indo-Bangla Pharmaceuticals, Millat Pharmaceuticals, MST Pharma and Healthcare, Orbit Pharmaceuticals, Pharmic Laboratories, Phoenix Chemical Laboratory, Rasa Pharmaceuticals and Save Pharmaceuticals.